Delivery Order SPE2DB24D2106-SPE2DB25FAUUT
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,000.98 contract is for the delivery of 4,567,329,296 lisdexamfetamine 20 mg capsules, and has an ultimate completion date of February 21, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,313.77 contract is for the supply of 4566838310 VYVANSE 50 MG CAPSULE 100S, with a performance period through January 6, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,690.11 contract is for the delivery of 10 mg dextroamphetamine-amphetamine capsules, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that allows the DLA to issue delivery...
This federal contract award, valued at $1,080.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the supply of 4567457194 - LISDEXAMFETAMINE 10 MG CAPSULE 100S, with a performance period ending on March 5, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,136.96 firm fixed-price contract is for the supply of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract has an ultimate completion date of July 11, 2023 and is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,586.00 placed under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued up to $499,999,999, allows the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products, including branded and generic medications, biologics, and medical supplies, to support the recurring medical needs of Department of Defense...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,724.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Vyvanse 70 mg capsules to support the recurring medical supply needs of military health facilities. This delivery order falls under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of Methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA). The $2,453.48 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a wide range of...
This contract award, valued at $1,164.82, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565874491 - VYVANSE 10 MG CAPSULE 100S, with an ultimate completion date of September 20, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,724 contract is for the delivery of 100 capsules of the medication Vyvanse (70 mg) with an ultimate completion date of December 4, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price...